DE69503885T2 - Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz - Google Patents

Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz

Info

Publication number
DE69503885T2
DE69503885T2 DE69503885T DE69503885T DE69503885T2 DE 69503885 T2 DE69503885 T2 DE 69503885T2 DE 69503885 T DE69503885 T DE 69503885T DE 69503885 T DE69503885 T DE 69503885T DE 69503885 T2 DE69503885 T2 DE 69503885T2
Authority
DE
Germany
Prior art keywords
alzheimer
disease
genetic markers
pct
diagnostics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69503885T
Other languages
English (en)
Other versions
DE69503885D1 (de
Inventor
Philippe Amouyel
Marie-Christin Chartier-Harlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Publication of DE69503885D1 publication Critical patent/DE69503885D1/de
Application granted granted Critical
Publication of DE69503885T2 publication Critical patent/DE69503885T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
DE69503885T 1994-03-07 1995-03-06 Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz Expired - Lifetime DE69503885T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402603A FR2716894B1 (fr) 1994-03-07 1994-03-07 Marqueurs génétiques utilisés conjointement pour le diagnostic de la maladie d'Alzheimer, méthode et kit de diagnostic.
PCT/FR1995/000259 WO1995024504A1 (fr) 1994-03-07 1995-03-06 Marqueurs genetiques utilises conjointement pour le diagnostic de la maladie d'alzheimer, methode et kit de diagnostic

Publications (2)

Publication Number Publication Date
DE69503885D1 DE69503885D1 (de) 1998-09-10
DE69503885T2 true DE69503885T2 (de) 1999-04-22

Family

ID=9460754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69503885T Expired - Lifetime DE69503885T2 (de) 1994-03-07 1995-03-06 Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz

Country Status (9)

Country Link
US (1) US5942392A (de)
EP (1) EP0749498B1 (de)
JP (1) JP3662585B2 (de)
AT (1) ATE169343T1 (de)
CA (1) CA2184635C (de)
DE (1) DE69503885T2 (de)
DK (1) DK0749498T3 (de)
FR (1) FR2716894B1 (de)
WO (1) WO1995024504A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
ES2128265B1 (es) * 1997-06-04 2000-03-01 Euroespes S A Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
FR2765591B1 (fr) * 1997-07-01 2002-08-09 Pasteur Institut Procede de diagnostic de la maladie d'alzheimer
AU734779B2 (en) * 1997-09-12 2001-06-21 Bristol-Myers Squibb Company Method for determining propensity for developing late-onset Alzheimer's disease
US6251587B1 (en) 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
EP1001037A3 (de) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Vorselektion und Isolierung eines Einzelnukleotidpolymorphismus
ATE225405T1 (de) * 1999-07-09 2002-10-15 Pasteur Institut Verfahren zur diagnose oder zur prognose von alzheimer krankheit: therapeutische zusammensetzung zur verhinderung oder zur behandlung von alzheimer krankheit
US7682795B2 (en) * 2002-07-30 2010-03-23 The J. David Gladstone Institutes Method of diagnosing Alzheimer's Disease
EP1623996A1 (de) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Verbessertes Verfahren zur Auswahl eines Proteins von einer Bibliothek
EP1876244A4 (de) * 2005-04-04 2009-09-23 Asubio Pharma Co Ltd Verfahren zum relativen risiko des ausbruchs atopischer dermatitis mit einzelnukleotidpolymorphismus-genanalyse
US9335331B2 (en) * 2005-04-11 2016-05-10 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
CA2604095A1 (en) 2005-04-12 2006-10-19 454 Life Sciences Corporation Methods for determining sequence variants using ultra-deep sequencing
US20060228721A1 (en) 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
EP2121984A2 (de) * 2007-03-16 2009-11-25 454 Life Sciences Corporation System und verfahren zur erkennung von hiv-arzneiresistenten varianten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3265577B2 (ja) * 1992-10-13 2002-03-11 デューク・ユニバーシティ アポリポ蛋白ｅの４型イソ型の測定法

Also Published As

Publication number Publication date
DE69503885D1 (de) 1998-09-10
CA2184635A1 (fr) 1995-09-14
US5942392A (en) 1999-08-24
EP0749498A1 (de) 1996-12-27
CA2184635C (fr) 2008-11-18
WO1995024504A1 (fr) 1995-09-14
JP3662585B2 (ja) 2005-06-22
FR2716894B1 (fr) 1996-05-24
DK0749498T3 (da) 1999-05-10
EP0749498B1 (de) 1998-08-05
ATE169343T1 (de) 1998-08-15
JPH09511138A (ja) 1997-11-11
FR2716894A1 (fr) 1995-09-08

Similar Documents

Publication Publication Date Title
DE69503885T2 (de) Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz
DE60031007D1 (de) Selektion von Bindungs-Bereichen für Zinkfingerproteine und Design-Methoden für Zinkfingerproteine, geeignet zur Bindung an solche vorselektierte Bereiche
AU6147096A (en) Use of nucleic acid ligands in flow cytometry
CA2316808A1 (en) Transgenic rabbit that expresses a functional human lipoprotein (a)
EP0788307A4 (de) Oligonukleotidmodulation von multidrogenresistenz-assoziertem protein
EP1246114A3 (de) Verfahren zur Genomanalyse
ATE364696T1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
DE69631540D1 (de) Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
ATE349551T1 (de) Verfahren und zusammensetzungen zur bestimmung von perioperativen genomprofile
DE59309183D1 (de) Simultane sequenzierung von nukleinsäuren
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
Murry Owning genes: disputes involving DNA sequence patents
MXPA02008239A (es) Gen humano de la esquizofrenia.
DE69535901D1 (de) Proteinkinase npk-110
CA2370666A1 (en) A tenascin-c isoform as a marker for neoplasias
ATE328077T1 (de) Gen assoziiert mit iga glomerulonephritis
GB9610281D0 (en) Diagnostic method and apparatus
AU4136797A (en) Novel semaphorin gene: semaphorin y
DE69332375T2 (de) Hundecoronavirus s gen und verwendung davon
ATE225405T1 (de) Verfahren zur diagnose oder zur prognose von alzheimer krankheit: therapeutische zusammensetzung zur verhinderung oder zur behandlung von alzheimer krankheit
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
ATE319826T1 (de) Minimale promotoren und ihre verwendung
TW200502244A (en) Expression of zebrafish bone morphogenetic protein 4
WO2002092850A3 (en) Diagnostic method for osteoporosis and related disorders
ATE331784T1 (de) Verfahren zur diagnose von fettsucht

Legal Events

Date Code Title Description
8364 No opposition during term of opposition